| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/17/2002 | US20020005205 Joint repair using mesenchymal stem cells |
| 01/17/2002 | US20020005028 Methods of producing a terminally sterilized topical patch preparation |
| 01/17/2002 | DE10031741A1 Externally applied oxygen carrier preparation for treating oxygen deficiency states of the skin, comprises active agent, specifically hemoglobin or its mixture with myoglobin, incorporated in a gel carrier |
| 01/17/2002 | DE10031132A1 Verfahren zur Herstellung aktivstoffhaltiger Kapseln mit ultradünner Wandschicht Process for the preparation aktivstoffhaltiger capsules with an ultra-thin layer |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2416050A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | CA2415778A1 Methods of therapy with thrombin derived peptides |
| 01/17/2002 | CA2415658A1 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 01/17/2002 | CA2415237A1 Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation |
| 01/17/2002 | CA2415158A1 Biologically active protein conjugates formed by first protecting activesite |
| 01/17/2002 | CA2415092A1 Novel aerosol formulation containing a polar fluorinated molecule |
| 01/17/2002 | CA2415082A1 Method for formulating healthcare products with enhanced stability |
| 01/17/2002 | CA2415081A1 Drug delivery system for poorly water soluble drugs |
| 01/17/2002 | CA2415080A1 Improved thyroid hormone formulations |
| 01/17/2002 | CA2415058A1 Pharmaceutical compositions of estrogenic agents |
| 01/17/2002 | CA2414926A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/16/2002 | EP1172373A2 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 01/16/2002 | EP1172114A2 Stable concentrated insulin preparations for pulmonary delivery |
| 01/16/2002 | EP1172101A1 The use of nimesulide for the treatment of psoriasis and psoriatic arthritis |
| 01/16/2002 | EP1172100A1 Oral solid pharmaceutical formulations with ph-dependent multiphasic release |
| 01/16/2002 | EP1172098A1 Pharmaceutical compositions comprising ketotifen |
| 01/16/2002 | EP1172041A2 Compositions of plant carbohydrates as dietary supplements |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171507A1 Core-shell tectodendrimers |
| 01/16/2002 | EP1171471A1 Enhanced gel strength methylcellulose |
| 01/16/2002 | EP1171231A1 Formulation arrays and use thereof |
| 01/16/2002 | EP1171164A2 Intracellular pharmaceutical targeting |
| 01/16/2002 | EP1171159A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/16/2002 | EP1171155A2 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/16/2002 | EP1171153A2 Novel medical use of alpha-1-acidic glycoprotein (aag) or orosomucoid |
| 01/16/2002 | EP1171150A2 Pseudomycin antifungal compositions and methods for their use |
| 01/16/2002 | EP1171136A2 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 01/16/2002 | EP1171134A1 Controlled release of sildenafil delivered by sublingual or buccal administration |
| 01/16/2002 | EP1171132A1 Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
| 01/16/2002 | EP1171111A2 Granulate with high content of l-carnitine or an alkanoyl l-carnitine |
| 01/16/2002 | EP1171109A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 01/16/2002 | EP1171105A1 Transdermal therapeutic system with a highly effective neuroleptic agent |
| 01/16/2002 | EP1171104A2 Transdermal therapeutic system with neutralized acrylic adhesive patch |
| 01/16/2002 | EP1171101A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
| 01/16/2002 | EP1171100A1 Solubilized pharmaceutical composition for parenteral administration |
| 01/16/2002 | EP1171099A1 Composition containing opioid antagonists and spray dispenser |
| 01/16/2002 | EP1171097A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate |
| 01/16/2002 | EP1171096A1 Cosmetic preparations |
| 01/16/2002 | EP1171091A1 Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones |
| 01/16/2002 | EP1171057A1 Cell-culture and polymer constructs |
| 01/16/2002 | EP1171003A1 Complete feed for fish larvae and method for preparing same |
| 01/16/2002 | EP0988322B1 Ultra-fine microcrystalline cellulose compositions and process for their manufacture |
| 01/16/2002 | EP0969811B1 Mixtures of alkylphosphoric acid esters and their use as cosmetic and pharmaceutical emulsifiers |
| 01/16/2002 | EP0859626B1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 01/16/2002 | EP0830132B1 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation |
| 01/16/2002 | EP0786088B1 Presentation of lipoarabinomannan antigens to t-cells by cd1 molecules |
| 01/16/2002 | EP0772434B1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
| 01/16/2002 | CN1331606A Oil-in-water emulsion exhibiting protective action against damages to human organs resulting from peroxidation and prodn. and use thereof |
| 01/16/2002 | CN1331604A Compsn. consisting of influenza virus surface proteins and dispensing device |
| 01/16/2002 | CN1331596A Controlled release galantamine composition |
| 01/16/2002 | CN1331592A Liposomic niflumic acid-new transdermal anti-inflammatory medicine |
| 01/16/2002 | CN1331590A Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating disease associated with increase of AT-1 or AT-2 receptors |
| 01/16/2002 | CN1331587A Spray-type consmetic compsn. and matrix used in said compsn. for dermal administration |
| 01/16/2002 | CN1331585A Spray on bandage and drug delivery system |
| 01/16/2002 | CN1331584A Method for preparing effervescent granulate comprising iron gluconate granulate thus obtained and tablets containing same |
| 01/16/2002 | CN1331583A Process for producing spherical fine particles contg drug |
| 01/16/2002 | CN1331582A Propofol compsn. comprising gentetate |
| 01/16/2002 | CN1331581A Pharmaceutical aerosol compsn. contg. HFA227 and HFA 137 |
| 01/16/2002 | CN1331580A Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 01/16/2002 | CN1331576A Methods and transdermal compsns. for pain relief |
| 01/16/2002 | CN1330956A Permanent-magnet colloid for plastic self-viscose magnetcally osmosizing ointment and its preparing process |
| 01/16/2002 | CN1330921A Method of mfg. slowly-released microball by combined milk process |
| 01/16/2002 | CN1077800C Cyclosporin soft capsule compsn. |
| 01/15/2002 | US6339151 Forming compounds using a nucleic acid base with a phosphorous halide to form drugs for nonproliferation of cells |
| 01/15/2002 | US6339107 Methods for treatment of Emphysema using 13-cis retinoic acid |
| 01/15/2002 | US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6339067 Covalently forming a polymer, from monomers, in presence of a polyion, wherein the polymer is formed outside of any cell, resulting in polymer--polyion complex for delivery to a cell, wherein polyion is not removed from complex |
| 01/15/2002 | US6339062 Retroinverso polypeptides that mimic or inhibit thrombospondin activity |
| 01/15/2002 | US6339060 For therapy of infections caused by microorganisms |
| 01/15/2002 | US6338904 Polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
| 01/15/2002 | US6338859 Polymeric micelle compositions |
| 01/15/2002 | US6338858 Topical aqueous gel composition |
| 01/15/2002 | US6338843 Polysaccharide dextrin bonded to doxorubicin |
| 01/15/2002 | US6338838 Dibenzoylmethane ultraviolet radiation screening agents |
| 01/15/2002 | CA2121604C Diagnosis and treatment of bacterial dysentery |
| 01/15/2002 | CA2094727C Hydrogen-containing chlorofluorocarbon aerosol medicaments |
| 01/15/2002 | CA2035403C Washing compounds containing non soluble silicone and a surfactant agent of the polyoxyalkyl carboxylic etheracid tye and their applica tion in the field of cosmetology and dermatology |
| 01/15/2002 | CA2008638C Process for preparing non-ionic surfactants from 2,2-dimthyl-4- [(oxiran-2-ylmthoxy)mthyl]-1,3-dioxolane and a carboxylic acid; new non-ionic surfactants and their use |
| 01/14/2002 | CA2352496A1 Oral solid pharmaceutical formulations with ph-dependent multiphasic release |
| 01/10/2002 | WO2002002790A1 Peptide-mediated ocular cell transfection |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002751A2 Alteration of cell membrane |
| 01/10/2002 | WO2002002641A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | WO2002002597A2 Peptide extended glycosylated polypeptides |
| 01/10/2002 | WO2002002595A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002509A1 Compounds and compositions for delivering active agents |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002222A1 Method for producing capsules containing an active ingredient and having an ultra-thin coating |
| 01/10/2002 | WO2002002189A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 01/10/2002 | WO2002002182A2 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |